Sort
39,280 grants matching “leukemia”
POSITIONAL CLONING OF THE MEN1 GENE
$544,018Settara Chandrasekharappa · National Human Genome Research Institute · ZIA · FY2009 · HG
Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia
$543,982David T Scadden · Dana-Farber Cancer Inst · U54 · FY2016 · CA
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
$543,901Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Regulation and tumorigenesis of non-classical RAS oncoproteins - Resubmission
$543,820Pau Castel · New York University School Of Medicine · R01 · FY2025 · CA
Regulation and tumorigenesis of non-classical RAS oncoproteins - Resubmission
$543,820Pau Castel · New York University School Of Medicine · R01 · FY2024 · CA
Mechanistic Evaluations of ILC2 Cells for the Treatment/Prevention of GVHD
$543,763Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · R01 · FY2019 · HL
Mechanistic Evaluations of ILC2 Cells for the Treatment/Prevention of GVHD
$543,763Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · R01 · FY2020 · HL
Mechanistic Evaluations of ILC2 Cells for the Treatment/Prevention of GVHD
$543,763Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · R01 · FY2017 · HL
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells
$543,694Johannes Zakrzewski · Hackensack University Medical Center · R37 · FY2023 · CA
The role of inflammation in the regulation of immune response in acute myeloid leukemia
$543,631Iannis Aifantis · New York University School Of Medicine · R01 · FY2024 · CA
Novel Indication for Myeloid Progenitor Use: Induction of Tolerance in Solid Organ Transplantation
$543,567Swapna Panuganti · Cellerant Therapeutics, Inc. · R42 · FY2019 · AI
Role of Runx1 in Pathologic Ocular Angiogenesis
$543,541Leo A Kim · Schepens Eye Research Institute · R01 · FY2018 · EY
Identification of causal factors underlying cognitive deficits in a mouse model of childhood leukemia survival
$543,381Teresa M Reyes · University Of Cincinnati · R01 · FY2020 · NR
Targeted therapy of ALL with gene-modified central memory T cells
$543,264Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA
lncRNA regulation of glioblastoma progression and therapeutic resistance
$543,237Jennifer S Yu · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · NS
NOVEL LENTIVIRAL PSEUDOTYPES
$543,137James K. Willson · Weill Medical Coll Of Cornell Univ · P01 · FY2008 · HL
Optimizing HER2-targeting using RNA- and DNA-based predictive algorithms
$542,931Lisa A Carey · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia
$542,925Tait D Shanafelt · Mayo Clinic Rochester · R01 · FY2015 · CA
The Role of miR-142 in the Transformation of Clonal Hematopoietic Disorders into AML
$542,890Guido Marcucci · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
The Role of miR-142 in the Transformation of Clonal Hematopoietic Disorders into AML
$542,890Guido Marcucci · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance
$542,767Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors
$542,666Michael J Borowitz · Johns Hopkins University · R01 · FY2007 · CA
Role of targeting ATPases BRG1/BRM in therapy of AML
$542,663Warren Campbell Fiskus · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Validation of Therapeutic Target Genes in Human Liver Cancer
$542,657Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Targeting the Ig-light chains with CAR-T cells in lymphoid tumors
$542,644Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA